Mu opioid receptor (OPRM1) as a predictor of treatment outcome in opiate-dependent individuals of Arab descent

References

• TsuangMTLyonsMJMeyerJMCo-occurrence of abuse of different drugs in men: the role of drugs-specific and shared vulnerabilitiesArch Gen Psychiatry1998559679729819064
   PubMed Web of Science ®Google Scholar
• AnthonyJCWarnerLAKesslerRCComparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the national comorbidity surveyExp Clin Psychopharmacol19942244268
   Web of Science ®Google Scholar
• HulseGKEnglishDRMilneEThe quantification of mortality resulting from the regular use of illicit opiatesAddiction19999422122910396790
   PubMed Web of Science ®Google Scholar
• NuttDKingLASaulsburyWBlakemoreCDevelopment of a rational scale to assess the harm of drugs of potential misuseLancet20073691047106317382831
   PubMed Web of Science ®Google Scholar
• BamentDCookeRWeekleyJAliRTreatment outcomes at 12 months post admission to drug treatment: The third report of the South Australian component of the Australian Treatment Outcomes Study – Heroin Adelaide: DASC Monograph No 16 Research Series2004
   Google Scholar
• BallJRossAThe Effectiveness of Methadone Maintenance TreatmentNew York, NYSpringer-Verlag1991
   Google Scholar
• JohnsonBAAddiction Medicine: Science and PracticeNew York, NYSpringer2011
   Google Scholar
• EapCBBuclinTBaumannPInterindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependenceClin Pharmacokinet2002411153119312405865
   PubMed Web of Science ®Google Scholar
• CrettolSDéglonJJBessonJABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatmentClin Pharmacol Ther20068066868117178267
   PubMed Web of Science ®Google Scholar
• SrisurapanontMJarusuraisinNNaltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trialsInt J Neuropsychopharmacol20058226728015850502
   PubMed Web of Science ®Google Scholar
• StreetonCWhelanGNaltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trialsAlcohol2001366544552
   Web of Science ®Google Scholar
• KranzlerHRVan KirkJEfficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysisAlcohol Clin Exp Res20012591335134111584154
   PubMed Web of Science ®Google Scholar
• BouzaCAngelesMMunozAAmateJEfficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic reviewAddiction200499781182815200577
   PubMed Web of Science ®Google Scholar
• AntonRFO'MalleySSCirauloDACOMBINE Study Research Group. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trialJAMA2006295172003201716670409
   PubMed Web of Science ®Google Scholar
• GelernterJKranzlerHCubellsJGenetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjectsMol Psychiatry1999447648310523821
   PubMed Web of Science ®Google Scholar
• AntonRFOrosziGO'MalleySAn evaluation of mu opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the combined pharmacotherapies and behavioral interventions for alcohol dependence (COMBINE) studyArch Gen Psychiatry200865213514418250251
   PubMed Web of Science ®Google Scholar
• KimSGKimCMKangDHAssociation of functional opioid receptor genotypes with alcohol dependence in KoreansAlcohol Clin Exp Res20042898699015252283
   PubMed Web of Science ®Google Scholar
• GianoulakisCKrishnanBThavundayilJEnhanced sensitivity of pituitary β-endorphin to ethanol in subjects at high risk of alcoholismArch Gen Psychiatry19965332502578611062
   PubMed Web of Science ®Google Scholar
• HaileCNKostenTAKostenTRPharmacogenetic treatments for drug addiction: alcohol and opiatesAm J Drug Alcohol Abuse200834435538118584566
   PubMed Web of Science ®Google Scholar
• KreekMJVocciFJHistory and current status of opioid maintenance treatments: blending conference sessionJ Subst Abuse Treat20022329310512220607
   PubMed Web of Science ®Google Scholar
• KreekMJBartGLillyCPharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatmentsPharmacol2005571126
   Google Scholar
• RavindranathanAJoslynGRobertsonMFunctional characterization of human variants of the mu opioid receptor geneProc Natl Acad Sci U S A200910626108111081619528663
   PubMed Web of Science ®Google Scholar
• BeyerAKochTSchröderHSchulzSHolltVEffect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu opioid receptorJ Neurochem20048955356015086512
   PubMed Web of Science ®Google Scholar
• VolpicelliJRAltermanAIHayashidaMO'BrienCPNaltrexone in the treatment of alcohol dependenceArch Gen Psychiatry199249118768801345133
   PubMed Web of Science ®Google Scholar
• DoleVPNyswanderMA medical treatment for diacetylmorphine (heroin) addiction. A clinical trial with methadone hydrochlorideJAMA196519364665014321530
   PubMed Web of Science ®Google Scholar
• BenyheSTóthGKeveiJCharacterization of rat brain opioid receptors by (Tyr-3, 5-3H)1,D-Ala2,Leu5-enkephalin bindingNeurochem Res1985106276352989719
   PubMed Web of Science ®Google Scholar
• ChenYMestekALiuJHurleyJAYuLMolecular cloning and functional expression of a μ-opioid receptor from rat brainMol Pharmacol1993448128393525
   PubMed Web of Science ®Google Scholar
• DelfsCLKongHMestekAExpression of mu opioid receptor mRNA in rat brain: an in situ hybridization study at single cell levelJ Comp Neurol199434546688089277
   PubMed Web of Science ®Google Scholar
• WaldhoerMBartlettSEWhistlerJLOpioid receptorsAnnu Rev Biochem20047395399015189164
   PubMed Web of Science ®Google Scholar
• HoeheMRKopkeKWendelBSequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependenceHum Mol Gene2000928952908
   PubMed Web of Science ®Google Scholar
• IkedaMRIdeSHanWHow individual sensitivity to opiates can be predicted by gene analysesTrend Pharmacol Sci200526311317
   PubMed Web of Science ®Google Scholar
• BergenAWKoskozkaJPetersonRMu opioid receptor gene variants: lack of association with alcohol dependenceMol Psychiatry199724904979399694
   PubMed Web of Science ®Google Scholar
• BondCLaforgeKSTianMSingle nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addictionProc Natl Acad Sci U S A19989516960896139689128
   PubMed Web of Science ®Google Scholar
• BefortKFilliolDDécaillotFMSingle nucleotide polymorphic mutation in the human mu opioid receptor severely impairs receptor signallingJ Biol Chem20012763130313711067846
   PubMed Web of Science ®Google Scholar
• ZhangYWangDJohnsonADPappACSadeeWAllelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118GJ Biol Chem200528038326183262416046395
   PubMed Web of Science ®Google Scholar
• AriasAFeinnRKranzlerHRAssociation of an Asn40Asp (A118G) polymorphism in the mu opioid receptor gene with substance dependence: a meta-analysisDrug and Alcohol Depend200683262268
   PubMed Web of Science ®Google Scholar
• OrosziGAntonRFO'MalleySOPRM1 Asn40Asp predicts response to naltrexone treatment: A haplotype based approachExp Clin Psychopharmacol2009333383393
   Google Scholar
• ZhangHLuoXKranzlerHRAssociation between two mu opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependenceHum Mol Genet20061580781916476706
   PubMed Web of Science ®Google Scholar
• KimSGKimCMChoiSWA mu opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patientsPsychopharmacology200920161161818795264
   PubMed Web of Science ®Google Scholar
• KarhuvaaraSSimojokiKVirtaATargeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicentre studyAlcohol Clin Exp Res2007311179118717451401
   PubMed Web of Science ®Google Scholar
• KrystalJHCramerJAKrolWFKirkGFRosenheckRANaltrexone in the treatment of alcohol dependenceN Engl J Med20013451734173911742047
   PubMed Web of Science ®Google Scholar
• OslinDWBerrettiniWKranzlerHRA functional polymorphism of the mu opioid receptor gene is associated with naltrexone response in alcohol-dependent patientsNeuropsychopharmacology2003281546155212813472
   PubMed Web of Science ®Google Scholar
• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders4th edWashington, D.C.American Psychiatric Association1994
   Google Scholar
• McLellanATCacciolaJKushnerHThe fifth edition of the addiction severity index: Cautions, additions and normative dataJ Subst Abuse Treat19929461480
   Web of Science ®Google Scholar
• McGueMPickensRWSvikisDSSex and age effects on the inheritance of alcohol problems: a twin studyJ Abnorm Psychol19921013171537970
   PubMed Web of Science ®Google Scholar
• BerrettiniWHPersicoAMDopamine D2 receptor gene polymorphisms and vulnerability to substance abuse in African-AmericansBiol Psychiatry1996401441478793046
   PubMed Web of Science ®Google Scholar
• BareLAManssonEYangDExpression of two variants of the human mu opioid receptor mRNA in SK-N-SH cells and human brainFEBS Lett199435422132167957926
   PubMed Web of Science ®Google Scholar
• XinLWangZJBioinformatics analysis of the human μ opioid receptor (OPRM1) splice and polymorphic variantsAAPS Pharm Sci20024113
   Google Scholar
• PasternakGWMultiple opiate receptors: déjà vu all over againNeuropharmacology2004131232315464147
   PubMed Web of Science ®Google Scholar
• LiuKMuseSVPowerMarker: integrated analysis environment for genetic marker dataBioinformatics2005212128212915705655
   PubMed Web of Science ®Google Scholar
• United Nations Office on Drug and Crime (UNODC), country profile, The Hashemite Kingdom of Jordan2010Vienna, Austria Available from: http://www.unodc.org/egypt/en/country_profile_jordan.html. Accessed December 11, 2011
   Google Scholar
• HadidiMSIbrahimMIAbdallatIMCurrent trends in drug abuse-associated fatalities – Jordan, 2000–2004Forensic Sci Int2009186444719217732
   PubMed Web of Science ®Google Scholar
• Di ChiaraGImperatoADrugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving ratsProc Natl Acad Sci U S A199885527452782899326
   PubMed Web of Science ®Google Scholar
• TandaGPontieriFEDi ChiaraGCannabinoid and heroin activation of mesolimbic dopamine transmission by a common m1 opioid receptor mechanismScience1997276204820509197269
   PubMed Web of Science ®Google Scholar
• WeissFLorangMTBloomFEKoobGFOral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens. Genetic and motivational determinantsJ Pharmacol Exp Ther19932672502588229752
   PubMed Web of Science ®Google Scholar
• NestlerEJGenes and addictionNat Genet200026227281
   Web of Science ®Google Scholar
• NestlerEJMolecular neurobiology of addictionAm J Addict20011020121711579619
   PubMed Web of Science ®Google Scholar
• NestlerEJOpportunities for understanding addictionJ Neurosci2001218324832711606619
   PubMed Web of Science ®Google Scholar
• NestlerEJIs there a common molecular pathway for addiction?Nat Neurosci200581445144916251986
   PubMed Web of Science ®Google Scholar
• HerzAEndogenous opioid systems and alcohol addictionPsychopharmacology1997129991119040115
   PubMed Web of Science ®Google Scholar
• LaforgeKSShickVSpanglerRDetection of single nucleotide polymorphisms of the human mu opioid receptor gene by hybridization or single nucleotide extension on custom oligonucleotide gelpad microchips: potential in studies of addictionAm J Med Genet20009660461511054767
   PubMed Web of Science ®Google Scholar
• EhlersCLLindPAWilhelmsenKCAssociation between single nucleotide polymorphisms in the mu opioid receptor gene (OPRM1) and self-reported responses to alcohol in American IndiansBio Med Central Medical Genetics2008935
   Google Scholar
• IdeSKobayashiHTanakaKGene polymorphisms of the mu opioid receptor in methamphetamine abusersAnn N Y Acad Sci2004102531632415542732
   PubMed Web of Science ®Google Scholar
• ZhangDShaoCShaoMEffect of mu opioid receptor gene polymorphisms on heroin-induced subjective responses in a Chinese populationBiol Psychiatry2007611244125117157823
   PubMed Web of Science ®Google Scholar
• LuoXKranzlerHRZhaoHGelernterJHaplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European-AmericansAm J Med Genet B Neuropsychiatr Genet200312019710812815747
   PubMed Web of Science ®Google Scholar
• AL-EitanLNJaradatADadourRTayGKHulseGKPolymorphisms in the μ-opioid receptor gene in Jordanian Arabs with opiate drug dependenceScience MED201239197
   Google Scholar
• Van der VeldenAWThomasAAThe role of the 5′ untranslated region of an mRNA in translation regulation during developmentInt J Biochem Cell Biol1999318710610216946
   PubMed Web of Science ®Google Scholar
• JansenRPmRNA localization: message on the moveNat Rev Mol Cell Biol2001224725611283722
   PubMed Web of Science ®Google Scholar
• BashirullahACooperstockRLLipshitzHDSpatial and temporal control of RNA stabilityProc Natl Acad Sci U S A2001987025702811416182
   PubMed Web of Science ®Google Scholar
• LötschJZimmermannMDarimontJDoes the A118G polymorphism at the mu opioid receptor gene protect against morphine-6-glucuronide toxicity?Anesthesiology20029781481912357145
   PubMed Web of Science ®Google Scholar
• OertelBGSchmidtRSchneiderAGeisslingerGLotschJThe mu opioid receptor gene polymorphism 118A > G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carriersPharmacogenet Genomics20061662563616906017
   PubMed Web of Science ®Google Scholar
• RombergRROlofsenEBijlHPolymorphism of mu opioid receptor gene (OPRM1:c.118A > G) does not protect against opioid-induced respiratory depression despite reduced analgesic responseAnesthesiology200510252253015731588
   PubMed Web of Science ®Google Scholar
• CrettolSBessonJCroquette-KrokarMAssociation of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatmentProg Neuropsychopharmacol Biol Psychiatry2008321722172718687376
   PubMed Web of Science ®Google Scholar
• GuoSWThompsonEAPerforming the exact test of Hardy-Weinberg proportion for multiple allelesBiometrics1992483613371637966
   PubMed Web of Science ®Google Scholar